Atomoxetine hydrochloride and Head injury - a phase IV clinical study of FDA data

Summary:

We study 729 people who have side effects when taking Atomoxetine hydrochloride. Head injury is found, especially among people who are female, 40-49 old, also take Tylenol and have Oral herpes.

The phase IV clinical study analyzes which people take Atomoxetine hydrochloride and have Head injury. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

729 people reported to have side effects when taking Atomoxetine hydrochloride.
Among them, 32 people (4.39%) have Head injury.

What is Atomoxetine hydrochloride?

Atomoxetine hydrochloride has active ingredients of atomoxetine hydrochloride. It is used in attention deficit hyperactivity disorder. Currently, eHealthMe is studying from 524 Atomoxetine hydrochloride users.

What is Head injury?

Head injury is found to be associated with 3,825 drugs and 3,158 conditions by eHealthMe. Currently, we are studying 151,201 people who have Head injury.

Number of Atomoxetine hydrochloride and Head injury reports submitted per year:

Could Atomoxetine hydrochloride cause Head injury?

* Approximation only. Some reports may have incomplete information.

Do you take Atomoxetine hydrochloride and have Head injury?

Check whether Head injury is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Head injury and when was it recovered:

Head injury in Atomoxetine hydrochloride

Expand to all the drugs that have ingredients of atomoxetine hydrochloride:

Head injury and drugs with ingredients of atomoxetine hydrochloride (237 reports)

Alternative drugs to, pros and cons of Atomoxetine hydrochloride:

Atomoxetine hydrochloride (524 reports)

Browse all side effects of Atomoxetine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Head injury treatments and more:

Head injury (151,201 reports)

Common drugs associated with Head injury:

All the drugs that are associated with Head injury:

Head injury (3,825 drugs)

Common conditions associated with Head injury:

Rheumatoid arthritis: 12,051 reports
Multiple sclerosis: 10,064 reports
High blood pressure: 6,065 reports
Osteoporosis: 6,034 reports
Pain: 5,104 reports
Atrial fibrillation/flutter: 4,548 reports
Depression: 4,421 reports

All the conditions that are associated with Head injury:

Head injury (3,158 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Atomoxetine hydrochloride) and Atomoxetine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.